These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23135645)

  • 1. Consideration of muscle mass in glabellar line treatment with botulinum toxin type A.
    Monheit G; Lin X; Nelson D; Kane M
    J Drugs Dermatol; 2012 Sep; 11(9):1041-5. PubMed ID: 23135645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy.
    Lorenc ZP; Smith S; Nestor M; Nelson D; Moradi A
    Aesthetic Plast Surg; 2013 Oct; 37(5):975-83. PubMed ID: 23846022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to onset of response of abobotulinumtoxina in the treatment of glabellar lines: a subset analysis of phase 3 clinical trials of a new botulinum toxin type A.
    Schlessinger J; Monheit G; Kane MA; Mendelsohn N
    Dermatol Surg; 2011 Oct; 37(10):1434-42. PubMed ID: 21745254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of botulinum toxin type A in cosmetic facial procedures.
    Jaspers GW; Pijpe J; Jansma J
    Int J Oral Maxillofac Surg; 2011 Feb; 40(2):127-33. PubMed ID: 20965695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Baumann L; Brandt FS; Kane MA; Donofrio LM
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S57-65. PubMed ID: 19945006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines.
    Lowe NJ; Shah A; Lowe PL; Patnaik R
    J Cosmet Laser Ther; 2010 Apr; 12(2):106-11. PubMed ID: 20151785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
    Alimohammadi M; Andersson M; Punga AR
    Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Rubin M; Dover J; Maas C; Nestor M
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S50-6. PubMed ID: 19945005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis.
    Yamauchi PS; Lowe NJ
    Clin Dermatol; 2004; 22(1):34-9. PubMed ID: 15158543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
    Prager W; Rappl T
    J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR; Arad S
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glabellar contraction patterns: a tool to optimize botulinum toxin treatment.
    de Almeida AR; da Costa Marques ER; Banegas R; Kadunc BV
    Dermatol Surg; 2012 Sep; 38(9):1506-15. PubMed ID: 22804914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation.
    Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB
    Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Injection techniques for the upper part of the face: forehead and periocular region].
    Gassia V; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S104-10. PubMed ID: 19576475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'Nefertiti lift': a new technique for specific re-contouring of the jawline.
    Levy PM
    J Cosmet Laser Ther; 2007 Dec; 9(4):249-52. PubMed ID: 18236245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R; Shome D; Jain V; Dikshit R
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
    Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
    Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the long-term safety data of repeat administrations of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Cohen JL; Schlessinger J; Cox SE; Lin X;
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S43-9. PubMed ID: 19945004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.